Literature DB >> 14665947

Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression.

Mototsugu Muramaki1, Hideaki Miyake, Sadao Kamidono, Isao Hara.   

Abstract

PURPOSE: We evaluated the effects of the over expression of CD44v8-10, one of the high molecular form of CD44, on the malignant potential of UM-UC-3 human bladder cancer cells in vitro and in vivo.
MATERIALS AND METHODS: We introduced CD44v8-10 complementary DNA into UM-UC-3 cells, which do not express detectable level of CD44v8-10 protein, and generated the CD44v8-10 over expressing cell line UM-UC-3/v8-10 and the vector only transfected cell line UM-UC-3/C. The effects of the introduction of CD44v8-10 into UM-UC-3 cells on the ability to bind hyaluronic acid (HA) were analyzed by the cell adhesion assay and the cell migration assay. We then evaluated tumor progression of UM-UC-3 sublines after subcutaneous and orthotopic injection into athymic nude mice.
RESULTS: There were no significant differences in in vitro growth rates. UM-UC-3/v8-10 cells showed significantly decreased binding and migration ability to HA but not to other extracellular matrix proteins. Furthermore, UM-UC-3/v8-10 cells demonstrated significantly increased tumor growth after subcutaneous as well as orthotopic injection into athymic nude mice and enhanced lymph node metastasis after orthotopic injection compared with UM-UC-3/C cells.
CONCLUSIONS: These findings suggest that CD44v8-10 over expression in human bladder cancer cells decreases their interaction with HA and potentiates their malignant progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14665947     DOI: 10.1097/01.ju.0000093446.54115.b6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.

Authors:  Mario W Kramer; Diogo O Escudero; Soum D Lokeshwar; Roozbeh Golshani; Obi O Ekwenna; Kristell Acosta; Axel S Merseburger; Mark Soloway; Vinata B Lokeshwar
Journal:  Cancer       Date:  2010-10-19       Impact factor: 6.860

2.  Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.

Authors:  Frida Holm; Eva Hellqvist; Cayla N Mason; Shawn A Ali; Nathaniel Delos-Santos; Christian L Barrett; Hye-Jung Chun; Mark D Minden; Richard A Moore; Marco A Marra; Valeria Runza; Kelly A Frazer; Anil Sadarangani; Catriona H M Jamieson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

3.  An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression.

Authors:  Mansoor Ahmed; Joseph L Sottnik; Garrett M Dancik; Divya Sahu; Donna E Hansel; Dan Theodorescu; Martin A Schwartz
Journal:  Cancer Cell       Date:  2016-09-01       Impact factor: 31.743

4.  CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy.

Authors:  Shujie Zhao; Chen Chen; Katherine Chang; Anand Karnad; Jaishree Jagirdar; Addanki P Kumar; James W Freeman
Journal:  Clin Cancer Res       Date:  2016-06-07       Impact factor: 12.531

5.  Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.

Authors:  S Zhu; Z Chen; A Katsha; J Hong; A Belkhiri; W El-Rifai
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

Review 6.  EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.

Authors:  Davide Pradella; Chiara Naro; Claudio Sette; Claudia Ghigna
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

7.  Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells.

Authors:  Elio Ziparo; Anna Riccioli; Chiara Di Stefano; Paola Grazioli; Rosaria Anna Fontanella; Paola De Cesaris; Antonella D'Amore; Michele Regno; Donatella Starace; Fabrizio Padula; Micol Elena Fiori; Rita Canipari; Antonella Stoppacciaro; Margherita Pesce; Antonio Filippini; Antonio Francesco Campese
Journal:  Oncotarget       Date:  2018-07-20

8.  hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing.

Authors:  Wei-Zhao Peng; Ji-Xi Liu; Chao-Feng Li; Ren Ma; Jian-Zheng Jie
Journal:  Cancer Cell Int       Date:  2019-12-12       Impact factor: 5.722

9.  The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.

Authors:  Christian Niedworok; Inga Kretschmer; Katharina Röck; Frank Vom Dorp; Tibor Szarvas; Jochen Heß; Till Freudenberger; Ariane Melchior-Becker; Herbert Rübben; Jens W Fischer
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

Review 10.  Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.

Authors:  Amira Abugomaa; Mohamed Elbadawy; Hideyuki Yamawaki; Tatsuya Usui; Kazuaki Sasaki
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.